Article thumbnail

Insulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study

By Stepani Bendel, Timo Koivisto, Olli-Pekka Ryynänen, Esko Ruokonen, Jarkko Romppanen, Vesa Kiviniemi and Ari Uusaro
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2007). Agha A: Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA
  2. (2009). Alexithymia and health-related quality of life in a general population. Psychosomatics
  3. (2002). AM: The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf)
  4. (2000). C: Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report.
  5. (2007). Casanueva FF, Kelestimur F: High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: A prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin Endocrinol (Oxf)
  6. (2004). Ceda GP: Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly.
  7. (2005). Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj
  8. (2006). Degli Uberti EC: Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome.
  9. (2006). Duijn CM: Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: The rotterdam study.
  10. (2005). GH deficiency as the most common pituitary defect after TBI: clinical implications. Pituitary
  11. (2008). Ghigo E: Diagnosis of adult GH deficiency. Pituitary
  12. (2005). Ghigo E: Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study.
  13. (2004). Ghigo E: Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: Screening study at 3 months after the brain injury. Clin Endocrinol (Oxf)
  14. (2009). GJ: Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol
  15. (2002). Hokken-Koelega AC: Acute stress response in children with meningococcal sepsis: Important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
  16. (2002). Hypos CCS Advisory Board, U.S.HypoCCS Study Group: Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab
  17. (2009). Insulin-like growth factor I. A potential neuroprotective compound for the treatment of acute ischemic stroke? Stroke
  18. (2002). Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation
  19. (2009). ML: Sensitivity and specificity of six Received:
  20. (2009). MW: Long-term health-related quality of life after aneurysmal subarachnoid hemorrhage: relationship with psychological symptoms and personality characteristics. Stroke
  21. (2002). On discriminative vs. generative classifiers: a comparison of logistic regression and naive bayes. Edited by: Dietterich
  22. (2000). Outcomes of early endovascular versus surgical treatment of ruptured cerebral aneurysms. A prospective randomized study. Stroke
  23. (2007). Quality of life and psychiatric sequelae following aneurysmal subarachnoid haemorrhage: Does neuroendocrine dysfunction play a role? Clin Endocrinol (Oxf)
  24. (2006). Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev
  25. (2004). Reinsturp P: Fatigue after aneurysmal subarachnoid hemorrhage evaluated by pituitary function and 3D-CBF. Acta Neurol Scand
  26. Ryynänen O-P: Predicting forensic admission among the mentally ill in a multinational setting: a Bayesian modelling approach.
  27. (1998). SR: Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. Growth Horm IGF Res
  28. (2001). The 15D instrument of health-related quality of life: properties and applications. Ann Med
  29. (2009). The impact of therapeutic modality on outcomes following repair of ruptured intracranial aneurysms: an administrative data analysis.
  30. (2009). Torres-Alemán I: Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan. Prog Neurobiol
  31. (2008). Uusaro A: Pituitary-adrenal function in patients with acute subarachnoid haemorrhage: A prospective cohort study. Crit Care
  32. (2007). Wallaschofski H: Normal levels of serum IGF-I: Determinants and validity of current reference ranges. Pituitary
  33. (2006). Zhang JH: Mechanisms of early brain injury after subarachnoid hemorrhage.